Eupraxia Pharmaceuticals Inc.
EPRX • Biotechnology
Strong market move
EPRX+12.00%
vs. previous close $7.50
$8.40
▲ +0.90 (+12.00%)
Current price
EarningsLatest report: Mar 31, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$216.95M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0Healthy liquidity · 15.12Weak profitability
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 12, 2026, 12:00 AM UTCLast profile update: Aug 13, 2026, 12:50 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$8.40
Change12.00%
Market Cap$216.95M
52W Range5.04 - 9.32
Beta1.50
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.00
Current Ratio15.12
Quick Ratio15.12
Target$17.00
Price$8.40
Change12.00%
Market Cap$216.95M
52W Range5.04 - 9.32
Beta1.50
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.00
Current Ratio15.12
Quick Ratio15.12
Target$17.00
Target Upside102.38%
Target Median$17.00
Target Range17.00 - 17.00
Volume218.62K
Avg Volume297.39K
EPS Surprise-0.01
Investment DNA
How strong this company looks for long-term investors
44
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
73/100
Why this score▼
Manageable debt level · 0Healthy liquidity · 15.12Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-08-13
Low
$17.00
Mean
$17.00
Median
$17.00
High
$17.00
🧾
No insider activity
No recent insider transactions available.